Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perioperative approaches to coagulation defects

K M Taylor1

  • 1Cardiac Surgical Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.

The Annals of Thoracic Surgery
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

US Army basic combat training alters the relationship between body mass index and per cent body fat.

BMJ military health·2021
Same author

Corrigendum to "ZnR/GPR39 upregulation of K<sup>+</sup>/Cl<sup>-</sup>-cotransporter 3 in tamoxifen resistant breast cancer cells" [Cell Calcium 81 (2019) 12-20].

Cell calcium·2019
Same author

Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.

The American journal of gastroenterology·2017
Same author

Phosphorylation of zinc channel ZIP7 drives MAPK, PI3K and mTOR growth and proliferation signalling.

Metallomics : integrated biometal science·2017
Same author

Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis.

Alimentary pharmacology & therapeutics·2016
Same author

Editorial: diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases.

Alimentary pharmacology & therapeutics·2015

Aprotinin, a serine protease inhibitor, effectively reduces bleeding and transfusion needs in cardiac surgery patients. This blood conservation strategy is crucial for minimizing complications associated with cardiac operations.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Hematology

Background:

  • Cardiac surgery often leads to bleeding complications and hemostatic defects.
  • Blood transfusions carry risks, making blood conservation a priority.
  • Patient-specific factors and surgical procedures can induce hemostatic issues.

Purpose of the Study:

  • To evaluate therapeutic approaches for managing bleeding in cardiac surgery.
  • To highlight the efficacy of aprotinin in reducing blood loss and transfusion requirements.
  • To discuss clinical use, dosage, and risk-benefit balance of aprotinin therapy.

Main Methods:

  • Review of therapeutic strategies including autotransfusion and pharmacotherapy.
  • Analysis of clinical data on aprotinin use in cardiac surgery patients.

Related Experiment Videos

  • Discussion of dosage regimens and monitoring of automated clotting time.

    • Main Results:

    • Aprotinin demonstrated significant and consistent efficacy in reducing bleeding.
    • Aprotinin therapy substantially decreased the need for blood and blood product transfusions.
    • High-risk patients particularly benefited from aprotinin's hemostatic effects.

    Conclusions:

    • Aprotinin is a highly effective drug for managing bleeding in cardiac surgery.
    • Its use contributes to blood conservation and reduces transfusion-related risks.
    • Careful consideration of indications and risk-benefit is essential for aprotinin therapy.